New RSV antibody shows promise for vulnerable babies in japan
NCT ID NCT06042049
First seen Apr 26, 2026 · Last updated May 15, 2026 · Updated 4 times
Summary
This study tested a medicine called nirsevimab in 33 Japanese infants under 1 year old who have health problems like heart or lung disease, weak immune systems, Down syndrome, or were born early. The goal was to see if two doses given 5-6 months apart are safe and help protect against RSV, a serious respiratory virus. The study is complete and focused on safety and how the body responds to the medicine.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Bunkyō City, 113-8519, Japan
-
Research Site
Fuchu-shi, 183-8561, Japan
-
Research Site
Fukuoka, 813-0017, Japan
-
Research Site
Kitakyusyu-shi, 806-8501, Japan
-
Research Site
Kōtoku, 135-8577, Japan
-
Research Site
Kurume-shi, 830-0011, Japan
-
Research Site
Nagasaki, 852-8501, Japan
-
Research Site
Saitama-shi, 336-8522, Japan
-
Research Site
Yokohama, 232 8555, Japan
Conditions
Explore the condition pages connected to this study.